{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:21:57Z","timestamp":1768450917947,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1994,10,1]],"date-time":"1994-10-01T00:00:00Z","timestamp":780969600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1994,10]]},"DOI":"10.1007\/bf02245067","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T13:39:39Z","timestamp":1132061979000},"page":"237-241","source":"Crossref","is-referenced-by-count":20,"title":["Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats"],"prefix":"10.1007","volume":"116","author":[{"given":"M.","family":"Poncelet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Souilhac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gueudet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Terranova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Gully","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Le Fur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Soubri\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02245067_CR1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-8993(91)90139-M","volume":"557","author":"NRF Al-Rhodan","year":"1991","unstructured":"Al-Rhodan NRF, Richelson E, Gilbert JA, Mc Cormick DJ, Kanba KS, Pfenning MA, Larson EW, Yaksh TL (1991) Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem. Brain Res 557:227\u2013235","journal-title":"Brain Res"},{"key":"BF02245067_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0304-3940(90)90721-K","volume":"108","author":"AJ Bean","year":"1990","unstructured":"Bean AJ, During MJ, Roth RH (1990) Effects of dopamine autoreceptor stimulation on the release of colocalized transmitters: in vivo release of dopamine and neurotensin from rat prefrontal cortex. Neurosci Lett 108:143\u2013148","journal-title":"Neurosci Lett"},{"key":"BF02245067_CR3","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0028-3908(85)90190-X","volume":"24","author":"CT Dourish","year":"1985","unstructured":"Dourish CT, Hutson PH (1985) Bilateral lesions of the striatum induced with 6-hydroxydopamine abolish apomorphine-induced yawning in rats. Neuropharmacology 24:1051\u20131055","journal-title":"Neuropharmacology"},{"key":"BF02245067_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0304-3940(92)90698-7","volume":"140","author":"MJ During","year":"1992","unstructured":"During MJ, Bean AJ, Roth RH (1992) Effects of CNS stimulants on the in vivo release of the colocalized transmitters, dopamine and neurotensin, from rat prefrontal cortex. Neurosci Lett 140:129\u2013133","journal-title":"Neurosci Lett"},{"key":"BF02245067_CR5","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1073\/pnas.89.12.5591","volume":"89","author":"K Fuxe","year":"1992","unstructured":"Fuxe K, O'Connor WT, Antonelli T, Osborne PG, Tanganelli S, Agnati LF, Ungerstedt U (1992) Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum. Proc Natl Acad Sci 89:5591\u20135595","journal-title":"Proc Natl Acad Sci"},{"key":"BF02245067_CR6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1073\/pnas.90.1.65","volume":"90","author":"D Gully","year":"1993","unstructured":"Gully D, Canton M, Boigegrain R, Jeanjean F, Molimard JC, Poncelet M, Gueudet C, Heaulme M, Leyris R, Brouard A, Pelaprat D, Labb\u00e9-Julli\u00e9 C, Mazella J, Soubri\u00e9 P, Maffrand JP, Rost\u00e8ne W, Kitabgi P, Le Fur G (1993) Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc Natl Acad Sci 90:65\u201369","journal-title":"Proc Natl Acad Sci"},{"key":"BF02245067_CR7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0091-3057(91)90307-N","volume":"38","author":"FB Jolicoeur","year":"1991","unstructured":"Jolicoeur FB, Gagne MA, Rivest R, Drumheller A, St-Pierre S (1991) Neurotensin selectively antagonizes apomorphine-induced stereotyped climbing. Pharmacol Biochem Behav 38:463\u2013465","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245067_CR8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0165-0173(93)90008-N","volume":"18","author":"P W Kalivas","year":"1993","unstructured":"Kalivas P W (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Rev 18:75\u2013113","journal-title":"Brain Res Rev"},{"key":"BF02245067_CR9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0014-2999(89)90098-8","volume":"160","author":"KM Merchant","year":"1989","unstructured":"Merchant KM, Gibb JW, Hanson G.R. (1989) Role of dopamine D-1 and D-2 receptors in the regulation of neurotensin systems of the neostriatum and the nucleus accumbens. Eur J Pharmacol 160:409\u2013412","journal-title":"Eur J Pharmacol"},{"key":"BF02245067_CR10","first-page":"775","volume":"255","author":"KM Merchant","year":"1990","unstructured":"Merchant KM, Bush LG, Gibb JW, Hanson GR (1990) Neurotensin-dopamine interactions in the substantia nigra of the rat brain. J Pharmacol Exp Ther 255:775\u2013790","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245067_CR11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00310640","volume":"89","author":"M Morelli","year":"1986","unstructured":"Morelli M, Longoni R, Spina L, Di Chiara G (1986) Antagonism of apomorphine-induced yawning by SCH 23390: evidence against the autoreceptor hypothesis. Psychopharmacology 89:259\u2013260","journal-title":"Psychopharmacology"},{"key":"BF02245067_CR12","first-page":"337","volume":"225","author":"CB Nemeroff","year":"1983","unstructured":"Nemeroff CB, Luttinger D, Hernandez DE, Mailman RB, Mason GA, Davis GA, Widerl\u00f6v E, Frye GD, Kilts CA, Beaumont K, Breese GR, Prange AJ JR (1983) Interactions of neurotensin with brain dopamine systems: biochemical and behavioural studies. J Pharmacol Exp Ther 225:337\u2013345","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245067_CR13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0196-9781(91)90129-D","volume":"12","author":"D Nouel","year":"1991","unstructured":"Nouel D, Costentin J (1991) Inhibition of apomorphine-induced yawning and penile erection by neurotensin. Peptides 12:755\u2013759","journal-title":"Peptides"},{"key":"BF02245067_CR14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0028-3908(93)90057-A","volume":"32","author":"M Poncelet","year":"1993","unstructured":"Poncelet M, Santucci V, Paul R, Gueudet C, Lavastre S, Guitard J, Steinberg R, Terranova JP, Breli\u00e8re JC, Soubri\u00e9 P, Le Fur G (1993) Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742A. Neuropharmacology 32:605\u2013615","journal-title":"Neuropharmacology"},{"key":"BF02245067_CR15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00178206","volume":"349","author":"M Poncelet","year":"1994","unstructured":"Poncelet M, Gueudet C, Gully D, Soubri\u00e9 P, Le Fur G (1994) Turning behaviour induced by intrastriatal injection of neurotensin in mice: sensitivity to non-peptide neurotensin antagonists. Naunyn-Schmiedeberg's Arch Pharmacol 349:57\u201360","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF02245067_CR16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90134-6","volume":"50","author":"AJ Puech","year":"1978","unstructured":"Puech AJ, Simon P, Boissier JR (1978) Benzamides and classical neuroleptics: comparison of their actions using 6 apomorphine-induced effects. Eur J Pharmacol 50:291\u2013300","journal-title":"Eur J Pharmacol"},{"key":"BF02245067_CR17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0028-3908(91)90038-D","volume":"30","author":"R Rivest","year":"1991","unstructured":"Rivest R, Jolicoeur FB, Marsden CA (1991) Neurotensin causes a greater increase in the metabolism of dopamine in the accumbens than in the striatum in vivo. Neuropharmacology 30:25\u201333","journal-title":"Neuropharmacology"},{"key":"BF02245067_CR18","first-page":"1194","volume":"4","author":"B Sanz","year":"1993","unstructured":"Sanz B, Exposito I, Mora F (1993) Effects of neurotensin on the release of glutamic acid in the prefrontal cortex and striatum of the rat. NeuroReport 4:1194\u20131196","journal-title":"NeuroReport"},{"key":"BF02245067_CR19","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0028-3908(89)90194-9","volume":"28","author":"V Seutin","year":"1989","unstructured":"Seutin V, Massotte L, Dresse A (1989) Electrophysiological effects of neurotensin on dopaminergic neurones of the ventral tegmental area of the rat in vitro. Neuropharmacology 28:949\u2013954","journal-title":"Neuropharmacology"},{"key":"BF02245067_CR20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0014-2999(90)90361-9","volume":"187","author":"NA Singh","year":"1990","unstructured":"Singh NA, Bush LG, Gibb JW, Hanson GR (1990) Dopamine-mediated changes in central nervous system neurotensin systems: a role for NMDA receptors. Eur J Pharmacol 187:337\u2013344","journal-title":"Eur J Pharmacol"},{"key":"BF02245067_CR21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0304-3940(94)90851-6","volume":"166","author":"R Steinberg","year":"1994","unstructured":"Steinberg R, Bougault I, Souilhac J, Gully D, Le Fur G, Soubri\u00e9 P (1994) Blockade of neurotensin receptors by the antagonist SR 48692 partially prevents retrograde axonal transport of neurotensin in rat nigrostriatal system. Neurosci Letter 166:106\u2013108","journal-title":"Neurosci Letter"},{"key":"BF02245067_CR22","first-page":"336","volume":"93","author":"AJ Stoessel","year":"1987","unstructured":"Stoessel AJ, Dourish CT, Iversen SD (1987) Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra. Psychopharmacology 93:336\u2013342","journal-title":"Psychopharmacology"},{"key":"BF02245067_CR23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0006-8993(89)90627-6","volume":"502","author":"S Tanganelli","year":"1989","unstructured":"Tanganelli S, Von Euler G, Fuxe K, Agnati LF, Ungerstedt U (1989) Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum. Brain Res 502:319\u2013324","journal-title":"Brain Res"},{"key":"BF02245067_CR24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0091-3057(84)90229-6","volume":"21","author":"I Ushijima","year":"1984","unstructured":"Ushijima I, Yamada K, Inoue T, Tokunaga T, Furukawa T, Noda Y (1984) Muscarinic and nicotinic effects on yawning and tongue protruding in the rat. Pharmacol Biochem Behav 21:297\u2013300","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245067_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-7258(89)90046-6","volume":"43","author":"JL Waddington","year":"1989","unstructured":"Waddington JL, O'Boyle K.M. (1989) Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist. Pharmacol Ther 43:1\u201352","journal-title":"Pharmacol Ther"},{"key":"BF02245067_CR26","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/0024-3205(86)90397-8","volume":"39","author":"P Worms","year":"1986","unstructured":"Worms P, Gueudet C, Biziere K (1986) Induction of turning by direct intrastriatal injection of dopaminomimetic drugs in mice: pharmacological analysis of a simple screening model. Life Sci 39:2199\u20132208","journal-title":"Life Sci"},{"key":"BF02245067_CR27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1476-5381.1992.tb09037.x","volume":"105","author":"MR Zarrindast","year":"1992","unstructured":"Zarrindast MR, Jamshidzadeh A (1992) Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats. Br J Pharmacol 105:675\u2013678","journal-title":"Br J Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02245067\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T17:33:13Z","timestamp":1557941593000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02245067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,10]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,10]]}},"alternative-id":["BF02245067"],"URL":"https:\/\/doi.org\/10.1007\/bf02245067","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,10]]}}}